DEPARTMENT OF CELL BIOLOGY

15
DEPARTMENT OF CELL BIOLOGY DEPARTMENT OF CELL BIOLOGY Head: Dr. Jacek Bigda, Associate Professor Research Staff: Dr. Małgorzata Doszczak Dr. Patrycja Koszałka Dr. Zuzanna Dobrzańska Ph.D. Students: Marcin Okrój Arkadiusz Pierzchalski

description

DEPARTMENT OF CELL BIOLOGY. Head: Dr. Jacek Bigda, Associate Professor. Research Staff: Dr. Małgorzata Doszczak Dr. Patrycja Koszałka Dr. Zuzanna Dobrzańska. Ph.D. Students: Marcin Okrój Arkadiusz Pierzchalski. MAIN TOPIC. Mechanism of action of - PowerPoint PPT Presentation

Transcript of DEPARTMENT OF CELL BIOLOGY

Page 1: DEPARTMENT OF CELL BIOLOGY

DEPARTMENT OF CELL BIOLOGYDEPARTMENT OF CELL BIOLOGY

Head: Dr. Jacek Bigda, Associate Professor

Research Staff: Dr. Małgorzata Doszczak Dr. Patrycja Koszałka Dr. Zuzanna Dobrzańska

Ph.D. Students: Marcin Okrój Arkadiusz Pierzchalski

Page 2: DEPARTMENT OF CELL BIOLOGY

MAIN TOPICMAIN TOPIC

Mechanism of action of tumor necrosis factor (TNF)

in vitro & in vivo

TEACHINGTEACHING

cell biology, histology, immunology

Page 3: DEPARTMENT OF CELL BIOLOGY

DEPARTMENT OF CELL BIOLOGYDEPARTMENT OF CELL BIOLOGYresearch interestsresearch interests::

mechanism of IL-1-induced cytotoxicity;

intracellular signaling of tumor necrosis factor;

mechanism of toxicity of the anti-angiogenic fumagillin derivative, TNP-470;

mechanism of anti-tumor action of poly-RGD peptides;

mechanism of accelerated growth of hamster melanoma following LPS application.

Page 4: DEPARTMENT OF CELL BIOLOGY

U 937U 937 – – human histiocytic lymphomahuman histiocytic lymphoma

TNF-R55

F

N

TF

N

T F

N

T

TNF-R75

F

N

T

m

F

N

T

m

F

N

T

Page 5: DEPARTMENT OF CELL BIOLOGY

0

20

40

60

80

100

120

0 0,1 1 10 100 1000TNF (U/mL)

Żyw

otn

ość

kom

óre

k (

%)

U937 ATCC U937 M U937 G

Cycloheximide (CHX)

0

20

40

60

80

100

120

0 1 10 100 1000TNF (U/mL)

Żyw

otn

ość

ko

rek (

%)

U937 ATCC U937 M U937 G

U937 cell variantsU937 cell variants

Page 6: DEPARTMENT OF CELL BIOLOGY

U 937MU 937G U 937ATCC

0

20

40

60

80

100

1,25 2,5 5

I lość mTNF (tys. komórek CHO)

Żyw

otn

ość

ko

móre

k (

%)

mTNF Kontrola

0

20

40

60

80

100

1,25 2,5 5

I lość mTNF (tys. komórek CHO)

Ży

wo

tno

ść k

om

óre

k (

%)

mTNF Kontrola

0

20

40

60

80

100

1,25 2,5 5

I lość mTNF (tys. komórek CHO)

Ży

wotn

ość

kom

óre

k (

%)

mTNF Kontrola

0

20

40

60

80

100

120

1,25 2,5 5

I lość mTNF (tys. komórek CHO)

Żyw

otn

ość

ko

rek

(%)

Kontrola m/sTNF + CHX mTNF + CHX

0

20

40

60

80

100

120

1,25 2,5 5

I lość mTNF (tys. komórek CHO)

Żyw

otn

ość

ko

rek

(%)

Kontrola m/sTNF + CHX mTNF + CHX

0

20

40

60

80

100

120

140

1,25 2,5 5

I lość mTNF (tys. komórek CHO)

Żyw

otn

ość

ko

rek

(%)

Kontrola m/sTNF + CHX mTNF + CHX

Page 7: DEPARTMENT OF CELL BIOLOGY

IL-1 (U/ml)

0

20

40

60

80

100

120

140

C

ell

viab

ilti

y (%

)

IL-1/CHX IL-1/CHX/pAb anty-TNF

10 10 10 2 10 3 10 4 1 0

IL-1 (U/ml)

0

20

40

60

80

100

120

140

IL-1/CHX IL-1/CHX/mAb anty-TNF

C

ell

viab

ilit

y (%

)10 10 10 10 10 0 1 2 3 4

IL-1 cytotoxicityIL-1 cytotoxicity

Page 8: DEPARTMENT OF CELL BIOLOGY

supernatant dilutionsup IL-1/CHX

sup kontr.

sup IL-1

sup CHX

Cel

l via

bilit

y (%

) 4 0 1:4 1:2 1:1 1

0

20

40

60

80

100

120

C

ell v

iabi

lity

(%)

0 1:8 1:4 1:2 1

supernatant dilution

0

20

40

60

80

100

120

sup IL-1/CHX sup IL-1/CHX + pAb anty-TNF

IL-1 cytotoxicityIL-1 cytotoxicity

Page 9: DEPARTMENT OF CELL BIOLOGY

control

4 h

2 h

0,5 h

1 h

0

100

200

300

400

500

TN

F [

pg

/ml]

control

CHX

IL-1

IL-1/CHX

IL-1 cytotoxicityIL-1 cytotoxicity

Page 10: DEPARTMENT OF CELL BIOLOGY

Isotype control

Untreated

IL-1/CHX

Page 11: DEPARTMENT OF CELL BIOLOGY

Survival time of tumor-bearing hamsters

Time [days]

% cumulated survival

0,0

0,1

0,2

0,3

0,4

0,5

0,6

0,7

0,8

0,9

1,0

0 10 20 30 40 50 60 70 80 90 100 110

Ab

Ab-RGD

Ab-LPS

Ab-LPS-RGD

Page 12: DEPARTMENT OF CELL BIOLOGY

DEPARTMENT OF CELL BIOLOGYDEPARTMENT OF CELL BIOLOGYfinancial supportfinancial support::

Analysis of mechanism regulating secretion of TNF following application of interleukin 1 and cycloheximide; State Committee for Scientific Research, Poland (2002-2005);

Mechanism of synergistic anti-tumor action of tumor necrosis factor (TNF) and angiogenesis inhibitor TNP-470; State Committee for Scientific Research, Poland (2001-2004);

Analysis of TNF sensitivity of variants of the U937 cell line; Intramural grant, Medical University of Gdańsk (2002-2003);

Modulation of tumor growth by means of cytokines; Core fund, Intercollegiate Faculty of Biotechnology UG-MUG;

Page 13: DEPARTMENT OF CELL BIOLOGY

DEPARTMENT OF CELL BIOLOGYDEPARTMENT OF CELL BIOLOGYselectedselected p previous grantsrevious grants::

Significance of tumor necrosis factor and its receptors for growth and dissemination of Bomirski melanoma; State Committee for Scientific Research, Poland (1994-1997);

Immunomodulatory and anti-tumor activity of cloned and purified rat tumor necrosis factor; State Committee for Scientific Research, Poland (1997-2000);

Influence of receptors of tumor necrosis factor for apoptosis of cancer cells; State Committee for Scientific Research, Poland (1997-2000);

Mechanism of cytotoxic action of interleukin 1; State Committee for Scientific Research, Poland (1999-2002);

TNF gene polymorphism and humoral reactivity against p53 protein in patients suffering from non-small cell lung cancer; State Committee for Scientific Research, Poland(1999-2002).

Page 14: DEPARTMENT OF CELL BIOLOGY

Tri-City Tri-City Central Animal LaboratoryCentral Animal Laboratory, , Medical University of GdańskMedical University of Gdańsk

Page 15: DEPARTMENT OF CELL BIOLOGY

Tri-CityTri-City Central Animal LaboratoryCentral Animal Laboratory, , Medical University of GdańskMedical University of Gdańsk